Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study.
- DOI
- 10.1007/s00259-026-08122-8
- Published
- 2026 Aug 12
- Container
- European journal of nuclear medicine and molecular imaging
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-026-08122-8,
title = {Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study.},
author = {Schmidt F and Lider SM and McDougall L and Eigler C and Bernhardt P and Mushaweh A and Bauman A and Fani M and Christ E and Wild D},
year = {2026},
journal = {European journal of nuclear medicine and molecular imaging},
doi = {10.1007/s00259-026-08122-8},
url = {https://doi.org/10.1007/s00259-026-08122-8}
}RIS
TY - JOUR TI - Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study. AU - Schmidt F AU - Lider SM AU - McDougall L AU - Eigler C AU - Bernhardt P AU - Mushaweh A AU - Bauman A AU - Fani M AU - Christ E AU - Wild D PY - 2026 JO - European journal of nuclear medicine and molecular imaging DO - 10.1007/s00259-026-08122-8 UR - https://doi.org/10.1007/s00259-026-08122-8 ER -
APA
F, S., SM, L., L, M., C, E., P, B., A, M., A, B., M, F., E, C., & D, W. (2026). Radiolabelled somatostatin receptor antagonist versus agonist for peptide receptor radionuclide therapy in patients with metastatic pheochromocytoma or paraganglioma: a retrospective pilot study.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-08122-8
Source records
- pubmed · retrieved 2026-09-25T19:23:29.952Z
- europe-pmc · retrieved 2026-09-25T19:23:29.963Z